Advances in Spatial Genomics
Agilent, Akoya to Commercialize Workflow Tools for Tissue Biomarker Analysis
The end-to-end workflow products are intended for biopharmaceutical companies developing companion diagnostics for precision cancer therapeutics.
Navignostics Using Single-Cell Spatial Proteomics to Guide Oncology Treatment, Drug Development
The University of Zurich spinout is using Standard BioTools' Hyperion system for its analyses and recently raised CHF 7.5 million in seed funding.
Proceeds from a recent European public offering will fund commercialization of the French company's Ikoniscope20 platform in the US and EU.
The acquisition of Cernostics and its TissueCypher Barrett's Esophagus Assay provides a route for Castle to enter gastrointestinal testing.
Castle Biosciences Acquires Cernostics for up to $80M
Cernostics specializes in spatial biology and artificial intelligence-driven image analysis of tissue biopsies.